These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 37649102

  • 1. GDF-15 and hepcidin as a therapeutic target for anemia in chronic kidney disease.
    Farag NM, Mousa M, Elsayed E, Ismeil A.
    Ital J Pediatr; 2023 Aug 30; 49(1):106. PubMed ID: 37649102
    [Abstract] [Full Text] [Related]

  • 2. Hepcidin and GDF-15 are potential biomarkers of iron deficiency anaemia in chronic kidney disease patients in South Africa.
    Nalado AM, Olorunfemi G, Dix-Peek T, Dickens C, Khambule L, Snyman T, Paget G, Mahlangu J, Duarte R, George J, Naicker S.
    BMC Nephrol; 2020 Sep 29; 21(1):415. PubMed ID: 32993549
    [Abstract] [Full Text] [Related]

  • 3. Hepcidin and proinflammatory markers in children with chronic kidney disease: A case-control study
.
    Goyal KK, Saha A, Sahi PK, Kaur M, Dubey NK, Goyal P, Upadhayay AD.
    Clin Nephrol; 2018 May 29; 89(5):363-370. PubMed ID: 29451472
    [Abstract] [Full Text] [Related]

  • 4. Physiological Role of Serum Growth Differentiation Factor-15 (GDF-15) Level and Iron Metabolism in Community-Dwelling Older Adults.
    Fukuda T, Yazawa H, Nishikawa R, Tokoi S, Kayashima R, Kono K, Sakuma M, Abe S, Toyoda S, Nakajima T.
    Cureus; 2024 May 29; 16(5):e60422. PubMed ID: 38883134
    [Abstract] [Full Text] [Related]

  • 5. Regulation of hepcidin through GDF-15 in cancer-related anemia.
    Jiang F, Yu WJ, Wang XH, Tang YT, Guo L, Jiao XY.
    Clin Chim Acta; 2014 Jan 20; 428():14-9. PubMed ID: 24384540
    [Abstract] [Full Text] [Related]

  • 6. Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study.
    Uehata T, Tomosugi N, Shoji T, Sakaguchi Y, Suzuki A, Kaneko T, Okada N, Yamamoto R, Nagasawa Y, Kato K, Isaka Y, Rakugi H, Tsubakihara Y.
    Nephrol Dial Transplant; 2012 Mar 20; 27(3):1076-83. PubMed ID: 21799206
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Study of growth differentiation factor-15 in polytransfused children with β-thalassemia.
    Meena S, Sharma K, Sharma S, Chandra J.
    Indian J Pathol Microbiol; 2023 Mar 20; 66(1):81-84. PubMed ID: 36656215
    [Abstract] [Full Text] [Related]

  • 9. Association of hepcidin and anemia in early chronic kidney disease.
    Sonkar SK, Singh NK, Sonkar GK, Pandey S, Bhosale V, Kumar A, Usman K.
    Saudi J Kidney Dis Transpl; 2019 Mar 20; 30(2):315-324. PubMed ID: 31031367
    [Abstract] [Full Text] [Related]

  • 10. Hepcidin/Ferritin Ratios Differ Among Non-Dialyzed Chronic Kidney Disease Patients, and Patients on Hemodialysis and Peritoneal Dialysis.
    Niikura T, Maruyama Y, Nakashima S, Matsuo N, Tanno Y, Ohkido I, Yokoyama K, Yamamoto H, Yokoo T.
    Ther Apher Dial; 2019 Aug 20; 23(4):341-346. PubMed ID: 30411489
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15.
    Fertrin KY, Lanaro C, Franco-Penteado CF, de Albuquerque DM, de Mello MR, Pallis FR, Bezerra MA, Hatzlhofer BL, Olbina G, Saad ST, da Silva Araújo A, Westerman M, Costa FF.
    Am J Hematol; 2014 Apr 20; 89(4):385-90. PubMed ID: 24860871
    [Abstract] [Full Text] [Related]

  • 14. GDF-15, iron, and inflammation in early chronic kidney disease among elderly patients.
    Lukaszyk E, Lukaszyk M, Koc-Zorawska E, Bodzenta-Lukaszyk A, Malyszko J.
    Int Urol Nephrol; 2016 Jun 20; 48(6):839-44. PubMed ID: 27043030
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hepcidin--a potential novel biomarker for iron status in chronic kidney disease.
    Zaritsky J, Young B, Wang HJ, Westerman M, Olbina G, Nemeth E, Ganz T, Rivera S, Nissenson AR, Salusky IB.
    Clin J Am Soc Nephrol; 2009 Jun 20; 4(6):1051-6. PubMed ID: 19406957
    [Abstract] [Full Text] [Related]

  • 18. The relationship between asymptomatic atherosclerosis and hepcidin-25 in chronic kidney disease patients.
    Mohamed ON, Mady AM, Sedik MM, Issa AS, Mohamed OM, Abdelhameed NI.
    Ann Saudi Med; 2023 Jun 20; 43(5):298-308. PubMed ID: 37805814
    [Abstract] [Full Text] [Related]

  • 19. Can Serum Gdf-15 be Associated with Functional Iron Deficiency in Hemodialysis Patients?
    Yilmaz H, Cakmak M, Darcin T, Inan O, Bilgic MA, Bavbek N, Akcay A.
    Indian J Hematol Blood Transfus; 2016 Jun 20; 32(2):221-7. PubMed ID: 27065587
    [Abstract] [Full Text] [Related]

  • 20. Hepcidin and risk of anemia in CKD: a cross-sectional and longitudinal analysis in the CKiD cohort.
    Atkinson MA, Kim JY, Roy CN, Warady BA, White CT, Furth SL.
    Pediatr Nephrol; 2015 Apr 20; 30(4):635-43. PubMed ID: 25380788
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.